Posted by Michael Wonder on 24 Jun 2020
NICE publishes final guidance for Sobi's avatrombopag maleate
24 June 2020 - Avatrombopag maleate is used to treat patients with thrombocytopenia.
Avatrombopag maleate is recommended, within its marketing authorisation, as an option for treating severe thrombocytopenia (that is, a platelet count of below 50,000 platelets per microlitre of blood) in adults with chronic liver disease having a planned invasive procedure.
